Current Posts – 04 Apr 2016

I have been heralding the arrival of a new super son-of-statin drug for months. One that gets cholesterol really, really low and is super expensive. Well it is here and it promises not to cause the awful muscle pains that affect at least 20% and maybe 40% of statin users, say its promoters. Isn’t that interesting? After years of being told statins were virtually side effect free. Who to believe?

Previous editorials...
Editorial

Editorial

Editor: Jerome Burne | editor@healthinsightuk.org
Editorial

Latest posts by Editorial (see all)

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann